Clinical Trial Update: A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating hetrombopag for chemotherapy-induced thrombocytopenia caused by gynecological tumor therapy; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia

Drugs mentioned

• Hetrombopag (hetrombopag)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Chemotherapy Induced Thrombocytopenia | Phase 2 | Status: NOT_YET_RECRUITING